Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Comparing intramuscular and intradermal injection of trivalent influenza vaccine, and topical imiquimod use before intradermal vaccination, on the post-vaccination immunogenicity, in patients on maintenance hemodialysis: A randomized clinical trial

Trial Profile

Comparing intramuscular and intradermal injection of trivalent influenza vaccine, and topical imiquimod use before intradermal vaccination, on the post-vaccination immunogenicity, in patients on maintenance hemodialysis: A randomized clinical trial

Completed
Phase of Trial: Phase III

Latest Information Update: 21 Dec 2017

At a glance

  • Drugs Imiquimod (Primary) ; Influenza virus vaccine (Primary) ; Influenza virus vaccine (Primary)
  • Indications Influenza virus infections
  • Focus Pharmacodynamics
  • Most Recent Events

    • 21 Dec 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top